OGN vs STRO
Organon & Co (OGN) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. STRO currently screens at market cap $470.8M.
Not investment advice. Open the OGN and STRO stock pages for the full models.
Not investment advice.